Join
Live feed
·
PRReleasevia Quantisnow
vTv Therapeutics Inc. logo

vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737

ByQuantisnow·Wall Street's wire, on your screen.
VTVT· vTv Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTVT (vTv Therapeutics Inc.) and more on Quantisnow.